Clinical Trials
This section provides information about recently completed clinical trials. If you cannot find information about a particular clinical trial, you should note that results may not be available even after the trial ends. Some trials end before completion and results are never published.
Latest Clinical Trial Results
M. D. Anderson-led team develops first-ever for African-Americans, expands previous model
HOUSTON, Sept. 5, 2008 – Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Sep 5, 2008 - Sarah Cannon Research Institute (SCRI) investigators have found that "smart bomb" therapies are effective in treating breast cancer patients while minimizing side effects.
Howard A. Burris III, M.D.,...
The study will be presented today in advance of the American Society for Clinical Oncology Breast Cancer Symposium.
Approximately 30 percent of breast cancer cells have an excess amount of the HER2 protein on their surface, which makes the...
BETHESDA, Md., Sept. 4, 2008--The Cancer Genome Atlas (TCGA) Research Network, a collaborative effort funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH),...
Dr. Jason Slingsby, CEO of ProtAffin commented: “I am encouraged that the FDA has approved the Orphan Drug designation for PA401 for the prevention of delayed graft function after solid organ transplantation. This encouraging...
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
VIENNA, Va., September 05, 2008 /PRNewswire-FirstCall/ -- CEL-SCI Corporation announced today that it presented new rheumatoid arthritis data at the Marcus Evans conference on Immunogenicity in Amsterdam. The data, presented by Dr. Daniel Zimmerman,...
SAN MATEO, Calif., September 04, 2008 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER & Co. GmbH...
NEW YORK--(BUSINESS WIRE)--Sep 5, 2008 - In the September 5 issue of the journal Cell, a group of researchers led by Richard Blumberg, MD, Chief of the Division of Gastroenterology, Hepatology and Endoscopy at the Brigham and Women's Hospital and...
WALTHAM, Mass.--(BUSINESS WIRE)--Sept. 5, 2008 - NeurAxon, Inc., a developer of next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced data from its Phase 2 clinical trial of NXN-188 in patients with...
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex Tablets
FLEMINGTON, N.J.--(BUSINESS WIRE)--Sep 4, 2008 - NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of...
MORGANTOWN, W.Va., September 05, 2008 /PRNewswire-USNewswire/ -- A team of researchers at has shown that U.S. immigrants from India and Pakistan take on the habits of their adopted country, increasing their risks of prostate cancer among male...
MUNICH--(BUSINESS WIRE)--Sep 4, 2008 - Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER(R) Sirolimus-eluting Coronary Stent was comparable to...
NANJING, China, Sept. 3 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group , a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu (also known as Endostar) in...
CENTENNIAL, Colo.--(BUSINESS WIRE)--Sep 5, 2008 - Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today that the principal researcher for its ICA-1 compound, Dr. Mildred Acevedo-Duncan, will present the work for ICA-1 entitled "PKC-i inhibition...
-Data Published in 'The Lancet' and Presented at ESC Congress-
PHILADELPHIA, September 04, 2008 /PRNewswire/ -- Results from a new international study, the GISSI Heart Failure (GISSI-HF) study, showed that 1 g/d dose of omega-3 acid ethyl esters...
Data are Consistent With Previously Announced Interim Findings
BIRMINGHAM, Ala., September 04, 2008 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals today announced results from the completed Phase IIa trial of BCX-4208 in patients with moderate...
- 100 mg cohort demonstrates potent antiviral activity and favorable safety profile -
CAMBRIDGE, Mass., September 04, 2008 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery and development...
DANBURY, Conn.--(BUSINESS WIRE)--Sep 3, 2008 - Biodel Inc. (Nasdaq: BIOD) announced today that it will report results of its two pivotal Phase III clinical trials of VIAject(TM) in patients with Type 1 and Type 2 diabetes next week at the 44th...
NIXA, Mo., September 03, 2008 /PRNewswire-USNewswire/-- A Centers for Disease Control and Prevention (CDC) study released today claims there is no link between the MMR vaccine and autism. The National Autism Association...
First Study to Control for Risk Factors of Smoking, Medication, Gastroesophageal Reflux and Demographics
PORTLAND, Ore., September 04, 2008 /PRNewswire/ -- Obese people who have asthma are nearly five times more likely to be hospitalized for the...
More...
